In this study we describe novel pH-sensitive PEGylated liposomes for site directed tumor targeting. pH-sensitive liposomes were obtained by including the amphiphilic molecule stearoyl-PEG-(sulfadimethoxine)11 in the liposome bilayer. At pH 6.5, the responsive nanosystem undergoes aggregation and selective association with tumor cells. The liposomes have stealth behavior at physiologic pH. Their responsiveness was found to be affected by the molar ratio of stearoyl-PEG-poly(sulfadimethoxine) assembled with the bilayer
Nanomedicine has been, to a certain degree, a success story in the development of superior anticance...
The functional and morphological alterations of the vascular endothelium of the lymphatic system, th...
Purpose. To characterize the ability of a novel pH-sensitive lipid to trigger the release of PEG-gra...
A novel pH-sensitive PEGylated liposome formulation for tumor targeting was investigated. The pH-sen...
The tumour tissue displays peculiar features, namely altered pH, temperature, redox potential and en...
The tumour tissue displays peculiar physiopathological features that can be exploited to yield site ...
Novel, acid-sensitive liposomes that respond to physiopathological pH for tumour targeting applicati...
In the latest years, investigations have been performed to develop smart stimuli responsive drug del...
A new acid sensitive nanocarrier based on lipid core micelles has been investigated for tumor target...
An innovative pH-switchable colloidal system that can be exploited for site-selective anticancer dru...
A new acid-sensitive drug-delivery nanocarrier has been developed for tumour targeting. The self-ass...
PEGylated liposomes are largely studied as long-circulating drug delivery systems. Nevertheless, the...
An innovative pH-switchable colloidal system that can be exploited for site-selective anticancer dru...
Stealth pH-responsive liposomes for the delivery of therapeutic proteins to the bladder epithelium w...
Targeting the anticancer agents selectively to cancer cells is desirable to improve the efficacy and...
Nanomedicine has been, to a certain degree, a success story in the development of superior anticance...
The functional and morphological alterations of the vascular endothelium of the lymphatic system, th...
Purpose. To characterize the ability of a novel pH-sensitive lipid to trigger the release of PEG-gra...
A novel pH-sensitive PEGylated liposome formulation for tumor targeting was investigated. The pH-sen...
The tumour tissue displays peculiar features, namely altered pH, temperature, redox potential and en...
The tumour tissue displays peculiar physiopathological features that can be exploited to yield site ...
Novel, acid-sensitive liposomes that respond to physiopathological pH for tumour targeting applicati...
In the latest years, investigations have been performed to develop smart stimuli responsive drug del...
A new acid sensitive nanocarrier based on lipid core micelles has been investigated for tumor target...
An innovative pH-switchable colloidal system that can be exploited for site-selective anticancer dru...
A new acid-sensitive drug-delivery nanocarrier has been developed for tumour targeting. The self-ass...
PEGylated liposomes are largely studied as long-circulating drug delivery systems. Nevertheless, the...
An innovative pH-switchable colloidal system that can be exploited for site-selective anticancer dru...
Stealth pH-responsive liposomes for the delivery of therapeutic proteins to the bladder epithelium w...
Targeting the anticancer agents selectively to cancer cells is desirable to improve the efficacy and...
Nanomedicine has been, to a certain degree, a success story in the development of superior anticance...
The functional and morphological alterations of the vascular endothelium of the lymphatic system, th...
Purpose. To characterize the ability of a novel pH-sensitive lipid to trigger the release of PEG-gra...